Valiant Organics
Ticker > Company >

Valiant Organics share price

Valiant Organics Ltd.

  1.03 L   320   29 NSE: VALIANTORG BSE: 540145 SECTOR: Chemicals

456.00
+52.10 (12.90%)
BSE: Today, 04:01 PM

Buy on Angel One

Price Summary

Today's High

₹ 467.15

Today's Low

₹ 401.05

52 Week High

₹ 441.8

52 Week Low

₹ 195.2

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1278.38 Cr.

Enterprise Value

₹ 1482.3 Cr.

No. of Shares

2.8 Cr.

P/E

26.3

P/B

1.78

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  256.36

CASH

₹ 7.43 Cr.

DEBT

₹ 211.36 Cr.

Promoter Holding

37.87 %

EPS (TTM)

₹  17.34

Sales Growth

6.14%

ROE

-0.45 %

ROCE

2.97%

Profit Growth

1.48 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year2.73%
3 Year-6.78%
5 Year5.16%

Profit Growth

1 Year1245.8%
3 Year-23.11%
5 Year-21.41%

ROE%

1 Year5.06%
3 Year1.38%
5 Year6.94%

ROCE %

1 Year6.86%
3 Year3.83%
5 Year8.43%

Debt/Equity

0.3103

Price to Cash Flow

28.86

Interest Cover Ratio

1.1019

CFO/PAT (5 Yr. Avg.)

1.49651981533302

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 37.87 0.00
Mar 2026 37.89 0.00
Dec 2025 37.89 0.00
Sep 2025 37.91 0.00
Jun 2025 37.91 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has an efficient Cash Conversion Cycle of 7.86709999999999 days.
  • The company has a good cash flow management; CFO/PAT stands at 1.49651981533302.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 7.61530905711777.

 Limitations

  • The company has shown a poor profit growth of -130.768358924447% for the Past 3 years.
  • The company has shown a poor revenue growth of -6.7841157077232% for the Past 3 years.
  • Company has a poor ROE of 1.3834% over the past 3 years.
  • Company has a poor ROCE of 3.83056666666667% over the past 3 years

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026
Net Sales 204.41 157.21 159.07 217.7 231.54
Total Expenditure 179.54 136.05 143.49 191.21 189.91
Operating Profit 24.87 21.16 15.58 26.49 41.62
Other Income 1.07 0.2 1.64 4.01 2.64
Interest 6.05 4.21 4.56 3.3 5.13
Depreciation 9.42 9.78 10.11 10.25 10.22
Exceptional Items 0 0 5.72 0 0
Profit Before Tax 10.48 7.36 8.27 16.95 28.92
Tax 2.91 1.76 2.2 1.83 7.09
Profit After Tax 7.58 5.6 6.06 15.12 21.82
Adjusted EPS (Rs) 2.71 2 2.16 5.4 7.78

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 948.45 911.62 677.19 718.76 738.38
Total Expenditure 783.41 781.63 638.07 664.79 650.2
Operating Profit 165.04 129.99 39.12 53.97 88.19
Other Income 5.56 2.92 3.34 8.25 6.91
Interest 6.35 10.54 19.38 24.05 18.2
Depreciation 27.29 27.63 33.97 35.76 39.57
Exceptional Items 0 4.9 5.75 0 5.72
Profit Before Tax 136.95 99.64 -5.14 2.41 43.06
Tax 34.01 24.07 -2.1 5.41 8.7
Net Profit 102.94 75.58 -3.04 -3 34.36
Adjusted EPS (Rs.) 37.91 27.83 -1.1 -1.07 12.26

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 27.56 27.56 27.58 28 28.02
Total Reserves 575.57 638.48 637.3 633.61 668.83
Borrowings 93.97 58.86 74.16 50.69 52.65
Other N/C liabilities 27.46 34.35 32.92 38.13 68.52
Current liabilities 358.32 346.55 370.32 328.88 312.83
Total Liabilities 1082.88 1105.79 1142.28 1079.32 1130.85
Assets
Net Block 508.88 609.8 630.49 644.49 682.6
Capital WIP 110.16 70.2 86.14 65.7 21.16
Intangible WIP 0 0 0 0 0
Investments 53.35 52.6 54.17 54.08 63.54
Loans & Advances 6.35 9.79 10.99 10.72 11.76
Other N/C Assets 0 0 0.06 0.05 0.18
Current Assets 404.14 363.4 360.44 304.28 351.62
Total Assets 1082.88 1105.79 1142.28 1079.32 1130.85
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 136.95 94.75 -10.89 2.41 43.06
Adjustment 32.48 40.69 51.67 56.93 54.03
Changes in Assets & Liabilities -152.98 64.68 45.52 -0.78 -55.33
Tax Paid -27.61 -17.57 -1.21 0 2.53
Operating Cash Flow -11.17 182.54 85.09 58.56 44.29
Investing Cash Flow -120.11 -90.63 -65.03 -27.06 -38.9
Financing Cash Flow 145.61 -108.61 -23.12 -27.65 -11.17
Net Cash Flow 14.34 -16.7 -3.05 3.85 -5.78

Corporate Actions

Investors Details

Annual Reports

Title Link
Title Link
Annual Report 2024
Annual Report 2021
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
Credit CRISIL
Credit CRISIL
TYPE AGENCY Link
TYPE AGENCY Link
Research Monarch Networth Capital
Research Monarch Networth Capital
Research Monarch Networth Capital
Research Monarch Networth Capital
Research Monarch Networth Capital

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
Concall Q4FY23
Concall Q4FY22
Concall Q3FY24
Concall Q1FY23
TYPE QUARTER Link
TYPE QUARTER Link
Presentation Q4FY22
Presentation Q4FY22
Presentation Q3FY26
Presentation Q3FY24
Presentation Q3FY23
Presentation Q3FY22
Presentation Q3FY22
Presentation Q3FY22
Presentation Q2FY23
Presentation Q1FY27
Presentation Q1FY26
Presentation Q1FY25
Presentation Q1FY25
Presentation Q1FY24

Company News

Valiant Organics Stock Price Analysis and Quick Research Report. Is Valiant Organics an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Valiant Organics. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Valiant Organics has a PE ratio of 23.3381786299347 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Valiant Organics has ROA of -0.2699% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Valiant Organics has a Current ratio of 0.9252.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Valiant Organics has a ROE of -0.4524%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Valiant Organics has a Debt to Equity ratio of 0.3196 which means that the company has low proportion of debt in its capital.

  • Sales growth: Valiant Organics has reported revenue growth of 6.1385% which is poor in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Valiant Organics for the current financial year is 7.45107767274218%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Valiant Organics is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Valiant Organics is Rs 17.3364. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Valiant Organics in Ticker for free. Also, one can get the intrinsic value of Valiant Organics by using Valuation Calculators, which are available with a Finology ONE subscription. 

Valiant Organics FAQs

Q1. What is Valiant Organics share price today?
Ans: The current share price of Valiant Organics is Rs 404.6.

Q2. What is the market capitalisation of Valiant Organics?
Ans: Valiant Organics has a market capitalisation of Rs 1134.2803206 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Valiant Organics?
Ans: The PE ratio of Valiant Organics is 23.3381786299347 and the P/B ratio of Valiant Organics is 1.57826411231811, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Valiant Organics share?
Ans: The 52-week high share price of Valiant Organics is Rs 442.1, and the 52-week low share price of Valiant Organics is Rs 195.

Q5. Does Valiant Organics pay dividends?
Ans: Currently, Valiant Organics does not pay dividends. Dividend yield of Valiant Organics is around 0%.

Q6. What are the face value and book value of Valiant Organics shares?
Ans: The face value of Valiant Organics shares is Rs 10, while the book value per share of Valiant Organics is around Rs 256.3576. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Valiant Organics?
Ans: Valiant Organics has a total debt of Rs 211.3569 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Valiant Organics?
Ans: The ROE of Valiant Organics is -0.4524% and ROCE of Valiant Organics is 2.9718%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Valiant Organics a good buy for the long term?
Ans: The Valiant Organics long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Valiant Organics undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Valiant Organics appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Valiant Organics’s financials?
Ans: You can review Valiant Organics’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Valiant Organics

Valiant Organics Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Valiant Organics Limited, a renowned name in the chemical industry, is a leading manufacturer of specialty chemicals and intermediates. The company was founded in [year] and has since achieved remarkable growth and success. With its commitment to quality and innovation, Valiant Organics has established itself as a reliable and trusted player in the market.

Valiant Organics Limited: Share Price

The stock price of Valiant Organics Limited reflects the market value of the company's shares. As a long-term stock investor, understanding the trends and movements of the share price is crucial. Our pre-built screening tools provide insightful analysis, enabling investors to make informed decisions based on historical and current share price data.

Valiant Organics Limited: Balance Sheet

Valiant Organics Limited's balance sheet provides a snapshot of the company's financial position. It showcases the company's assets, liabilities, and shareholders' equity. Utilizing our premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, investors can accurately assess the company's financial health and fair value.

Valiant Organics Limited: Annual Report

Valiant Organics Limited's annual report serves as a comprehensive overview of the company's performance over the year. Our website offers downloadable annual reports that provide detailed information about the company's operations, financial statements, management discussions, and analysis. These reports are vital resources for conducting thorough stock analysis.

Valiant Organics Limited: Dividend

Dividends are an important aspect for long-term stock investors seeking reliable returns. Valiant Organics Limited's dividend policy rewards its shareholders with regular payouts, reflecting the company's financial stability and profitability. By analyzing the company's dividend history and payout ratio, investors can evaluate the potential value of owning Valiant Organics' stock.

Valiant Organics Limited: Quarterly Result

Analyzing Valiant Organics Limited's quarterly results aids investors in tracking the company's performance on a shorter timeframe. Our platform offers easy access to quarterly reports, allowing investors to monitor important financial metrics, such as revenue, net income, and operating margins. This information facilitates a comprehensive evaluation of the company's financial standing.

Valiant Organics Limited: Stock Price

The stock price of Valiant Organics Limited is influenced by various factors, including market demand, industry trends, and company performance. By utilizing our pre-built screening tools and price charts, investors can track stock price movements, identify patterns, and make informed decisions regarding their investment strategies.

Valiant Organics Limited: Price Chart

Our website provides detailed stock price charts, allowing investors to visualize the trends and patterns in Valiant Organics Limited's stock price over different time periods. Price charts aid in identifying support and resistance levels, trend reversals, and potential entry or exit points. This data assists long-term investors in making well-informed investment decisions.

Valiant Organics Limited: News

Keeping up with the latest news and updates related to Valiant Organics Limited is crucial for understanding the factors that can impact the company's stock performance. Our platform offers a curated news section that provides timely and relevant information, helping investors stay informed and make informed decisions based on the latest developments.

Valiant Organics Limited: Concall Transcripts

Concall transcripts provide valuable insights into the discussions and decisions made during company conference calls with analysts and investors. Our website offers downloadable concall transcripts, making it convenient for investors to access and analyze the key takeaways from these discussions. These transcripts assist investors in understanding management strategies, growth plans, and key risks associated with Valiant Organics Limited.

Valiant Organics Limited: Investor Presentations

Investor presentations provide a comprehensive overview of Valiant Organics Limited's business strategy, operations, financial performance, and growth prospects. Our website offers downloadable investor presentations, allowing investors to delve deeper into the company's strategic initiatives, sector analysis, and competitive positioning. These presentations serve as valuable resources for long-term investors conducting thorough stock analysis.

Valiant Organics Limited: Promoters

The promoters of Valiant Organics Limited are key stakeholders who have a significant influence on the company's operations and decision-making processes. Our website provides information about the promoters, their background, and their contribution to the company's success. Understanding the promoters' track record and vision provides investors with valuable insights into the company's long-term prospects.

Valiant Organics Limited: Shareholders

Valiant Organics Limited's shareholders are an essential part of the company's ownership structure. Our website offers insights into the major shareholders, including institutional investors and retail investors. Monitoring changes in the shareholder base can provide investors with valuable information about market sentiment, investor confidence, and potential future developments.

Please note that all the relevant resources, such as annual reports, concall transcripts, investor presentations, and research reports, are provided as downloadable files on our website. These resources, combined with our pre-built screening tools and premium features, empower investors to conduct comprehensive stock analysis and make informed investment decisions for long-term success. 

Valiant Organics Reserves Analysis

Reviewing the balance sheet of Valiant Organics, we see a steady increase in total reserves from Rs 373.58 Cr in March 2020 to Rs 637.30 Cr in March 2024. This indicates a consistent retention of profits and a strengthening financial reserve base over the years.

Valiant Organics Debt Situation

The borrowings of Valiant Organics have undergone fluctuations, peaking at Rs 93.97 Cr in March 2022 before reducing to Rs 74.16 Cr by March 2024. This reflects the company's dynamic approach to managing its debt.

Valiant Organics Asset Growth

Valiant Organics has shown considerable growth in its asset base from Rs 629.02 Cr in March 2020 to Rs 1,142.28 Cr in March 2024. The net block, which is a significant component of the company's assets, has increased from Rs 255.65 Cr to Rs 630.49 Cr, suggesting considerable capital asset investments.

Valiant Organics Current Liabilities

The company's current liabilities have witnessed a growth, reaching Rs 371.90 Cr in March 2024, up from Rs 145.64 Cr in March 2020. This points to an increase in short-term financial obligations.

Valiant Organics Equity Structure

The share capital of Valiant Organics shows minimal changes, with a slight increase to Rs 27.58 Cr in March 2024 from Rs 14.37 Cr in March 2020. This indicates stability in the company's equity funding.

The data presented is an analysis for the Standalone Balance Sheet of Valiant Organics.

With Valiant Organics' steady growth, investors and market analysts monitoring NSE/BSE indices should consider these financial insights when assessing sector performance.

Read More
X